
|Articles|October 25, 2012
Risk of VTE Increased in New Users of Drospirenone
A retrospective cohort study of more than a half million new users of hormonal contraception shows that drospirenone is associated with a higher risk of thrombotic events than contraceptives containing low-dose estrogen.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Estrogen therapy shows mixed mental health effects in menopause
2
Cardiovascular disease prevention in women: A discussion with Erin Donnelly Michos, MD
3
Gene and inflammation factors heighten memory decline after early menopause
4
Understanding body composition changes during the menopausal transition, with Brooke Aggarwal, EdD
5




















